Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily dose of antiretroviral drugs.

New HIV research reveals how broadly neutralizing antibodies may transform treatment despite the virus's rapid mutation and ...

Researchers mapped more than 100 mutations that allow diverse HIV-1 strains to evade broadly neutralizing antibodies.

Between 25 and 30 percent of HIV-infected patients have a resistant strain of the virus which is not curable by current medications, but a recent Cornell study found that a new drug may be able to ...

An electronic 96-channel pipette was one of the tools used to scale up and allow the teamto perform over 7,000 parallel experiments that uncovered more than 100 bNAb escapemutations across 15 viral ...

In what may be one of the most important HIV research breakthroughs in years, scientists have discovered a strikingly powerful antibody, called 04_A06, that is able to neutralize nearly all of the ...

For the first time in 19 years, a team of scientists has detected a new strain of HIV. The strain is a part of the Group M version of HIV-1, the same family of virus subtypes to blame for the global ...

The UK Health Security Agency has identified a new hybrid mpox strain in England in a person who recently traveled to Asia. Genomic sequencing shows the strain is “recombinant,” combining elements of ...

Scientists from the National Institutes of Health have identified an antibody from an HIV-infected person that potently neutralized 98 percent of HIV isolates tested, including 16 of 20 strains ...

A US autopsy found drugresistant mpox replicating in the brain of a man with advanced HIV, raising concerns as global health ...